Search AI Products and News

Today, on the second anniversary of Baichuan Intelligent's founding, the company's founder and CEO Wang Xiaochuan released an all-staff letter, reviewing the past two years' achievements and shortcomings, and clarifying the company's current and future development direction. Wang Xiaochuan emphasized that Baichuan Intelligent will firmly pursue its technological vision and business direction in the medical field, promoting the deep application of AI technology in the medical industry through the path of "creating doctors - changing paths - promoting medicine".

A German research team has developed and released FIORA, an open-source graph neural network (GNN) model designed to improve the accuracy of mass spectrometry analysis. This advancement is expected to significantly contribute to the progress of precision medicine.

SoftBank Group has partnered with Tempus AI to create a new joint venture aimed at utilizing artificial intelligence (AI) to analyze personal medical data and provide treatment recommendations. SoftBank Group CEO Masayoshi Son announced the news at a press conference in Tokyo.